search for


Original Article
Clinical Courses and Outcome of Newly Diagnosed Immune Thrombocytopenia in Infants
Clin Pediatr Hematol Oncol 2018;25:97-101.
Published online October 31, 2018
© 2018 Korean Society of Pediatric Hematology-Oncology and Korean Society for Pediatric Neuro-Oncology

Nu Ri Hwang, M.D.1 and Kyung Duk Park, M.D.1,2

1Chonbuk National University Children's Hospital,
2Research Institute of Clinical Medicine of Chonbuk National University, Jeonju, Korea
Correspondence to: Kyung Duk Park
Department of Pediatrics, Chonbuk National University Children's Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju 54907, Korea
Tel: +82-63-250-1472
Fax: +82-63-250-1464
Received September 1, 2018; Revised September 19, 2018; Accepted September 29, 2018.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Infants with immune thrombocytopenia (ITP) are at increased risk of high risk bleeding and vaccination-associated ITP. Infants with ITP respond favorably to treatment and are less likely to develop chronic ITP compared to older children. However the characteristics of this entity in infants have rarely been analyzed. We investigated the clinical characteristics and response to treatment of newly diagnosed ITP in infants under 1 year of age.
Methods: We retrospectively reviewed the medical records of newly diagnosed ITP infants between 1 month to 11 months of age at Chonbuk National University Hospital from 2002 to 2017. The demographics, complete blood count, absolute lymphocyte count (ALC), absolute neutrophil count, vaccination history, upper respiratory infection, viral study (cytomegalovirus) and treatment of patients with ITP were reviewed.
Results: A total of 85 patients satisfied the criteria for newly diagnosed ITP. Of these patients, 83 were in complete remission, 6 were in persistent remission, and 2 progressed to chronic ITP. As a result of the study, 57 patients (67%) were male. 71 patients (83.5%) were secondary ITP. Among secondary ITP, vaccination related ITP was the most common cause with 60 patients (84.5%). The mean at diagnosis was 4.3±3.2 month. There was no statistically significant difference in ALC between the time of diagnosis and treatment. Hemoglobin was 10.8 g/dL at diagnosis and increased significantly to 12.3 g/dL after treatment.
Conclusion: Ninety-seven percent of ITP patients diagnosed under 1 year of age were in remission.
Keywords: Infants, Immune thrombocytopenia, Clinical course
  1. Kühne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143:605-8.
  2. Kwak JW, Lim YT. A comparative analysis according to age for acute idiopathic thrombocytopenic purpura in children: especially in infants under 1 year of age. Korean J Pediatr Hematol Oncol 2005;12:11-7.
  3. Ahmed I, Rajpurkar M, Thomas R, Chitlur M. Initial lymphocyte count and the development of persistent/chronic immune thrombocytopenic purpura. Pediatr Blood Cancer 2010;55:508-11.
    Pubmed CrossRef
  4. Deel MD, Kong M, Cross KP, Bertolone SJ. Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children. Pediatr Blood Cancer 2013;60:1967-74.
    Pubmed CrossRef
  5. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190-207.
    Pubmed CrossRef
  6. Shim YJ, Kim UH, Suh JK, Lee KS. Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience. Blood Res 2014;49:187-91.
    Pubmed KoreaMed CrossRef
  7. Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child 2000;83:220-2.
    Pubmed KoreaMed CrossRef
  8. ElAlfy M, Farid S, Abdel Maksoud A. Predictors of chronic idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2010;54:959-62.
  9. Imbach P, Kühne T, Müller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer 2006;46:351-6.
    Pubmed CrossRef
  10. Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005;94:178-84.
    Pubmed CrossRef
  11. Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol 2010;149:855-64.
    Pubmed CrossRef
  12. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 2001;27:253-67.
    Pubmed CrossRef
  13. Lee JY, Lee JH, Lee H, et al. Epidemiology and management of primary immune thrombocytopenia: A nationwide populationbased study in Korea. Thromb Res 2017;155:86-91.
    Pubmed CrossRef
  14. Lee T, Choi J, Lim YJ. Clinical course of childhood immune thrombocytopenic purpura and analysis predicting factor of prognosis. Clin Pediatr Hematol Oncol 2017;24:88-92.
  15. Trincado DE, Rawlinson WD. Congenital and perinatal infections with cytomegalovirus. J Paediatr Child Health 2001;37:187-92.
  16. Kim CS. Congenital and perinatal cytomegalovirus infection. Korean J Pediatr 2010;53:14-20.
  17. Choi SR, Kim KR, Kim DS, et al. The incidence of symptomatic congenital cytomegalovirus (CMV) infection in Korea;a 15-year multi-center study. Open Forum Infect Dis 2017;4:S690-1.
    KoreaMed CrossRef
  18. Jang JH, Kim JY, Mun YC, et al. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Res 2017;52:254-63.
    Pubmed KoreaMed CrossRef
  19. Glanz J, France E, Xu S, Hayes T, Hambidge S. A populationbased, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008;121:e506-12.
    Pubmed CrossRef

October 2018, 25 (2)
Full Text PDF
Send to a friend

Cited By Articles
  • CrossRef (0)

Author ORCID Information
  • Kyung Duk Park 

Funding Information